Oncolytics Biotech SEC Filing Effectiveness
Ticker: ONCY · Form: EFFECT · Filed: 2026-04-06T00:15:22-04:00
Sentiment: neutral
Topics: registration-statement, effectiveness, sec-filing
TL;DR
ONCO registration statement effective 4/6/26. Big step for them.
AI Summary
Oncolytics Biotech Inc. filed an EFFECT form on April 6, 2026, indicating the effectiveness of a registration statement. The filing relates to Act 33 and has the file number 333-294811. The company's mailing and business address is Suite 325, 4350 Executive Drive, San Diego, CA 92121.
Why It Matters
This filing signifies that a registration statement for Oncolytics Biotech Inc. has been declared effective by the SEC, which is a crucial step for certain securities offerings or transactions.
Risk Assessment
Risk Level: low — This is a procedural filing indicating the effectiveness of a registration statement, not a filing detailing significant financial changes or events.
Key Numbers
- 2026-04-06 — Filing Date (Date the EFFECT filing was accepted by the SEC.)
- 2026-04-03 — Effectiveness Date (The date the registration statement became effective.)
Key Players & Entities
- Oncolytics Biotech Inc. (company) — Filer
- 9999999995-26-001090 (dollar_amount) — SEC Accession Number
- 2026-04-06 (dollar_amount) — Filing Acceptance Date
- 2026-04-03 (dollar_amount) — Effectiveness Date
- 333-294811 (dollar_amount) — File Number
FAQ
What type of registration statement became effective?
The filing does not specify the exact type of registration statement, only that it is an 'EFFECT' filing indicating its effectiveness.
What is the CIK number for Oncolytics Biotech Inc.?
The CIK number for Oncolytics Biotech Inc. is 0001129928.
What is the company's state of incorporation?
Oncolytics Biotech Inc. is incorporated in Nevada (NV).
What is the SIC code for Oncolytics Biotech Inc.?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What is the SEC accession number for this filing?
The SEC accession number for this filing is 9999999995-26-001090.
From the Filing
EDGAR Filing Documents for 9999999995-26-001090 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form EFFECT - Notice of Effectiveness: SEC Accession No. 9999999995-26-001090 Accepted 2026-04-06 00:15:22 Documents 1 Effectiveness Date 2026-04-03 Document Format Files Seq Description Document Type Size 1 primary_doc.html EFFECT 1 primary_doc.xml EFFECT 592 Complete submission text file 9999999995-26-001090.txt 1729 Mailing Address SUITE 325, 4350 EXECUTIVE DRIVE SAN DIEGO CA 92121 Business Address SUITE 325, 4350 EXECUTIVE DRIVE SAN DIEGO CA 92121 4036707377 ONCOLYTICS BIOTECH INC (Filer) CIK : 0001129928 (see all company filings) EIN. : 980541667 | State of Incorp.: NV | Fiscal Year End: 1231 Type: EFFECT | Act: 33 | File No.: 333-294811 | Film No.: 26839473 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)